Antiretroviral Drugs Flashcards

1
Q

What are the Nucleoside/tide Reverse Transcriptase Inhibitors (NRTIs) and MOA?

A

MOA: lack of 3’OH terminates DNA elongation, competitive inhibitors of RT with activity against HIV-2/1

  • Abacavir
  • Didanosine
  • Emtricitabine
  • Lamivudine
  • Stavudine
  • Tenofovir (only nucleotide)
  • Zidovudine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Abacavir AE and DI

A

NRTI

AE: hypersensitivity reactions with fever, rash malaise, respiratory, and/or GI

DI: avoid alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Didanosine AE, DI

A

NRTI

AE: pancreatitis, peripheral neuropathy, GI disturbances, insulin resistance, retinal changes, optic neuritis

DI: Tenofovir, avoid concurrent neuropathic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Emtricitabine AE

A

NRTI

AE: well tolerated but can cause hyperpigmentation of the palms and soles (especially in dark skinned pts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lamivudine AE

A

NRTI

AE: well tolerated compared to other NRTIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stavudine AE, DI

A

NRTI

AE: hyperlipidemia, peripheral neuropathy, increased serum aminotransferase levels, diabetes, pancreatitis, fatal lactic acidosis

DI: avoid concurrent neuropathic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tenofovir AE, DI

A

NRTI

AE: generally well tolerated; renal toxicity, decreased bone density and osteomalacia can occur

DI: Tenofovir lowers serum concentrations of Atazanavir; combined use with didanosine has been associated with CD4+ decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Zidovudine AE, DI

A

NRTI

AE: bone marrow suppression, nausea, vomiting, headache, fatigue, confusion, malaise, hepatitis, diabetes

DI: myelosuppression may increase with coadministration of Ganciclovir, interferon alpha, Ribavirin, and other bone marrow suppressive agents; Coadministration with Doxorubicin or Stavudine should be avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) and MOA?

A

MOA: highly selective, noncompetitive inhibitors of HIV-1 RT and do not require phosphorylation

  • Efavirenz
  • Nevirapine
  • Rilpivirine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Efavirenz AE, DI

A

NNRTI

AE: difficulty concentrating, vivid dreams, nightmares, teratogenic in 1st trimester, rash diziness, HA, insomnia, reduction in vitamin D levels, and hyperlipidemia

DI: substrate of CYP3A4 and inducer of CYP3A4 and 2B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nevirapine AE, DI

A

NNRTI

AE: rash, fever, nausea, HA, severe, hepatotoxicity, hepative failure and death

DI: inducer of CYP3A4 and 2B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rilpivirine AE

A

NNRTI

AE: rash, insomnia, depression, increased liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the Protease Inhibitors and MOA?

A

MOA: reversible inhibitors of HIV aspartyl protease (which cleaves viral polyprotein into RT, protease, integrase)

  • Atazanavir
  • Darunavir
  • Indinavir
  • Lopinavir
  • Nelfinavir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atazanavir AE, DI

A

PI

AE: benign hyperbilirubinemia, rash, PR interval prolongation, nephrolithiasis

DI: concurrent use of drugs that increase gastric pH, such as PPIs, H2 blockers, and antacids may decrease absoprtion of Atazanavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Darunavir AE, DI

A

PI

AE: rash

DI: inhibits CYP3A4; avoid in pts with sulfur allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indinavir AE, DI

A

PI

AE: asymptomatic elevation of indirect bilirubin, nephrolithiasis, cholelithiasis, rash, blurred vision

DI: inhibits CYP3A4

17
Q

Lopinavir AE, DI

A

PI

AE: generally well tolereated, HA, asthenia, pancreatitis

DI: inhibits CYP3A4

18
Q

Nelfinavir AE, DI

A

PI

AE: generally well tolerated, diarrhea, nausea, and flatulence are common

DI: metabolized by severeal CYP enzymes (3A4 and 2C19)

19
Q

What are the Integrase Strand Transfer Inhibitors (INSTI) and MOA?

A

MOA: bind integrase causing inhibition of the final step in integration of viral DNA into host cell DNA

  • Bicetegravir
  • Dolutegravir
  • Elevitegravir
  • Raltegravir
20
Q

Bicetegravir PK, AE, DI

A

INSTI

PK: UGT1A1 and CYP3A4 substrate

AE: diarrhea, nausea, HA

DI: some CYP interactions

21
Q

Dolutegravir PK, AE, DI

A

INSTI

PK: UGT1A1 and CYP3A4 substrate

AE: diarrhea, headache, nausea

DI: some CYP interactions and contraindicated in pregnancy due to neural tube defects

22
Q

Elvitegravir PK, AE, DI

A

INSTI

PK: primarily CYP3A4 so requies PK enchancing with Cobicistat

AE: diarrhea, nausea, headache

DI: CYP interaction likely

23
Q

Raltegravir PK, AE, DI

A

INSTI

PK: primarily UGT1A1 substrate

AE: diarrhea, headache, nausea, and slight increase in creatine phosphokinases

DI: Rifampin, Tipranavir, and Efavirenz may decrease concentrations; PPIs may increase concentration

24
Q

What is the Fusion Inhibitor MOA and AE?

A

Enfuvirtide

MOA: structurally similar to gp41 preventing ability of virion to fuse cell membrane

AE: injection related hypersensitivity reactions and eosinophilia rarely

25
Q

Entry Inhibitor MOA and DI

A

Maraviroc

MOA: binds specifically and selectivity to CCR5 to block HIV entry

AE: well tolerated, risk of hepatotoxicity

26
Q

What are the Pharmacokinetic Enhancers and MOA

A

MOA: potent inhibitors of CYP 3A4, increase plasma concentrations of ARV allowing less frequent dosing with better tolerability

  • Ritonavir (protease inhibitor)
  • Cobicistat (usually combined with INSTI Elvitegravir and combination with Darunavir and Atazanavir)
27
Q

What are the 4 current preffered recommendations for Treatment-Naive pts?

A
  1. Bictegravir + Tenofovir + Emtricitabine
  2. Dolutegravir + Abacavir + Lamivudine (HLA-B*5701 negative)
  3. Dolutefravir + Tenofovir + Emtricitabine
  4. Raltegravir + Tenofovir + Emtricitiabine
28
Q

What is the recommendations for infant borne to HIV infected mother?

A
  • Nevirapine + Zidovudine
29
Q

What is the HIV prophylaxis following a needle stick?

A
  1. Raltegravir + Tenofovir + Emtricitabine
  2. Dolutegravir + Tenofovir + Emtricitabine